MolPort-002-045-698

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

37 API Suppliers, 13 USDMF, 8 CEP/COS, 3 JDMF, 1 EU WC, 5 KDMF, 9 NDC API, 24 Listed Suppliers, $ API Reference Price

INTERMEDIATES

1 API Suppliers

1 API Suppliers

FINISHED DOSAGE FORMULATIONS

128 FDF Dossiers, 35 FDA Orange Book, 40 Europe, 10 Canada, 24 Australia, 1 South Africa, 18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 0.25MCG, CAPSULE;ORAL - 0.5MCG, INJECTABLE;INJECTION - 0.001MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 0.002MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 16 SPI Pharma, 8 DKSH, 7 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 5 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 BASF, 1 Finar, 3 Gangwal Chemicals, 3 Ingredion Pharma Solutions, 4 Kerry, 3 Lonza Capsugel, 2 Microlex e.U, 3 Pluviaendo, 1 Qualicaps, 19 Roquette, 4 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

37 Fillers, Diluents & Binders, 18 Direct Compression, 16 Parenteral, 16 Taste Masking, 14 Chewable & Orodispersible Aids, 12 Film Formers & Plasticizers, 10 Coating Systems & Additives, 9 Co-Processed Excipients, 9 Thickeners and Stabilizers, 8 Empty Capsules, 8 Solubilizers, 8 Topical, 7 Disintegrants & Superdisintegrants, 4 Granulation, 3 Coloring Agents, 3 Controlled & Modified Release, 2 Emulsifying Agents, 2 Surfactant & Foaming Agents, 1 Soft Gelatin, 1 API Stability Enhancers